Historical development of health technology assessment in Thailand Teerawattananon Y*, Tantivess S*, Yothasamut J*, Kingkaew P *, Chaisiri K*. *Health Intervention and Technology Assessment Program, Thailand Objectives This study aims to review the development of health technology assessme

Over the past 5 years, HCUs (i.e., top 5% of the population) utilized ~50% of the annual health expenditure, confirming that even during the pandemic year of 2020, the HCU phenomenon still existed. The characteristics of HCU patients remained relatively the same from 2016 to 2020, in terms of pro

Two days after Debra Demidon underwent in vitro fertilization, she gained more than 30 pounds in fluid and suddenly was struggling to breathe.Doctors diagnosed severe ovarian hyperstimulation syndrome (OHSS), a complication seen in some women who undergo fertility treatment. It landed Ms. Demidon in

At the mention of peppermint, candy canes and ice cream comes to mind. But did you know that peppermint is also an age-old herbal medicine that has been used to treat a wide range of abdominal woes? The oil extracted from the peppermint plant contains a host of compounds, but the most abundant and p

This research aims to capture and estimate the budget impact of implementing the modified HEARTS protocol for an entire year to the entirety of primary care in Lumpang, Thailandcosting

This research aimed to develop the population-based preference scores of the EQ-5D-5L (the 5L), Thai version in an effort to compare the measurement properties of the 5L with those of the EQ-5D-3L (the 3L), and to compare the results of an economic evaluation from a 2014 study that used the 5L compared with the 3L. To elicit population-based prefer

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5 1Institute of Global Health Innovation, Imperial College London, London, UK 2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK 3Ce

Abstract Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and res